Galectin Therapeutics Inc.
USD4.54
-0.43 (-8.65%)
CEO
Joel Lewis
IPO Date
2002-09-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.03
Prev. Close
$4.97
Day Low
$4.53
Day High
$5.03
52W Low
$2.03
52W High
$7.13
Market Cap
$0.30B
Volume
0.17M
| -1.7 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 68.2% | -145.6% | -1.19 | 1.77 | -2.4 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 120.4% | -182.2% | -1.24 | 1.58 | -1.7 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -1166.9% | -73.0% | 11.11 | 4.63 | -4.0 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -97.0% | -79.3% | 0.00 | 5.46 | -5.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -29.2% | -27.4% | 0.00 | 17.10 | -11.2 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -201.5% | -154.3% | 0.00 | 4.19 | -9.7 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -1360.9% | -390.2% | 0.00 | 1.29 | -7.3 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -178.4% | -135.7% | 0.00 | 4.18 | -1.3 |
| -12.1 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | 6.5% | -63.6% | -0.98 | 0.09 | -8.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 6.4% | -48.2% | -1.03 | 1.43 | -4.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 8.6% | -101.1% | -0.96 | 0.08 | -2.0 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | 11.6% | -68.4% | -1.03 | 0.49 | -1.7 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | 12.1% | -38.7% | -1.13 | 1.13 | -3.8 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 15.1% | -44.7% | -1.14 | 1.87 | -3.0 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 16.2% | -44.4% | -1.16 | 2.02 | -3.3 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 16.6% | -35.5% | -1.19 | 1.77 | -2.5 |